BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6588925)

  • 21. [Comparative evaluation of combined chemotherapeutic regimens in acute non-lymphocytic leukemia].
    Sasaki H; Maekawa I; Kawamura S; Miyake T
    Hokkaido Igaku Zasshi; 1983 May; 58(3):271-8. PubMed ID: 6194091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute pancreatitis during the treatment of BH-AC AMP regimen for acute non-lymphocytic leukemia].
    Onozawa Y; Yahara Y; Imai Y; Kawaguchi K; Higashidani M; Yoshida M
    Rinsho Ketsueki; 1984 Nov; 25(11):1766-71. PubMed ID: 6543456
    [No Abstract]   [Full Text] [Related]  

  • 23. [A case of acute promyelocytic leukemia complicated with severe esophageal stenosis caused by aclacinomycin A].
    Kataoka T; Takeyama H; Watanabe E; Yano K
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1686-9. PubMed ID: 3861136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of acute non-lymphocytic leukemia in Saitama Cancer Center.
    Sampi K; Sakurai M; Kaneko Y; Hattori M
    Anticancer Res; 1985; 5(3):293-6. PubMed ID: 4015043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Aclarubicin-related pancreatitis in a child with AML].
    Adachi S; Akiyama Y; Takimoto T; Tanizawa A; Kiriyama Y; Kubota Y; Mikawa H
    Rinsho Ketsueki; 1988 Mar; 29(3):385-8. PubMed ID: 3165144
    [No Abstract]   [Full Text] [Related]  

  • 26. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group.
    Kobayashi T; Miyawaki S; Tanimoto M; Kuriyama K; Murakami H; Yoshida M; Minami S; Minato K; Tsubaki K; Ohmoto E; Oh H; Jinnai I; Sakamaki H; Hiraoka A; Kanamaru A; Takahashi I; Saito K; Naoe T; Yamada O; Asou N; Kageyama S; Emi N; Matsuoka A; Tomonaga M; Ohno R
    J Clin Oncol; 1996 Jan; 14(1):204-13. PubMed ID: 8558199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of conventional chemotherapy and short-term intensive chemotherapy in adult acute myeloid leukemia].
    Ohshima T
    Rinsho Ketsueki; 1989 Aug; 30(8):1175-7. PubMed ID: 2601028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of follow-up studies on prognosis after immunotherapy with bestatin in acute nonlymphocytic leukemia].
    Ota K; Kurita S; Yamada K; Masaoka T; Uzuka Y; Ogawa N
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1017-25. PubMed ID: 3963846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ABEP chemotherapy in the treatment of advanced non-Hodgkin's lymphomas].
    Yoshida T; Nakanishi J; Ito K; Kobayashi K; Ohtake S; Nakamura S; Matsuda T; Nakagoshi T; Natori K; Nakamura E
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):984-9. PubMed ID: 3963862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia].
    Taguchi H; Kubonishi I; Takehara N; Uemura Y; Iwahara Y; Eguchi T; Miyagi T; Sugito S; Muneishi H; Tanaka Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1309-14. PubMed ID: 1503485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behenoyl cytosine arabinoside, daunorubicin, 6-mercaptopurine, and prednisolone combination therapy for acute myelogenous leukemia in adults and prognostic factors related to remission duration and survival length.
    Ohno R; Kato Y; Nagura E; Murase T; Okumura M; Yamada H; Ogura M; Minami S; Suzuki H; Morishima Y
    J Clin Oncol; 1986 Dec; 4(12):1740-7. PubMed ID: 3465875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical studies of BH-AC-DMP in adult acute nonlymphocytic leukemia].
    Kato Y; Kawashima K; Ohno R; Yamada K
    Nihon Ketsueki Gakkai Zasshi; 1983 Sep; 46(5):1077-86. PubMed ID: 6582751
    [No Abstract]   [Full Text] [Related]  

  • 33. Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG).
    Ohno R; Kobayashi T; Morishima Y; Hiraoka A; Imai K; Asoh N; Tsubaki K; Tomonaga M; Takahashi I; Kodera K
    Leukemia; 1992; 6 Suppl 2():92-5. PubMed ID: 1578954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Progress in the treatment of adult acute myeloid leukemia].
    Ohno R
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1053-8. PubMed ID: 9239156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
    Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D
    Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Full remission of acute non-lymphatic leukemia lasting for 16 months following combination therapy with aclacinomycin A].
    Beck JD
    Monatsschr Kinderheilkd; 1986 Aug; 134(8):547-9. PubMed ID: 3464845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Remission induction by ACM-A and BH-AC on acute promyelocytic leukemia which is resistant to DNR and CA (author's transl)].
    Shimazaki C; Nakajima Y; Ura Y; Hamami T; Haruyama H; Isemura T; Nakagawa M; Ijichi H
    Rinsho Ketsueki; 1981 Jul; 22(7):1116-22. PubMed ID: 6948970
    [No Abstract]   [Full Text] [Related]  

  • 38. Aclarubicin in the treatment of elderly patients with acute nonlymphocytic leukemia.
    Takahashi I; Yorimitsu S; Hara M; Inagaki T; Nakada H; Sekito N; Hayashi N; Nonaka K; Ohmoto E; Uchida K
    Acta Med Okayama; 1986 Jun; 40(3):175-7. PubMed ID: 3461685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A phase III study of BHAC-MMP (behenoyl-ara-C, mitoxantrone, 6-mercaptopurine prednisolone) in acute leukemia. Hanshin Cooperative Study Group of Hematological Disorders].
    Masaoka T; Shibata H; Nagai K; Kanamaru A; Horiuchi A; Kitani T; Yonezawa T; Kawagoe H; Yasunaga K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2829-34. PubMed ID: 3530140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experience with using aclarubicin in the treatment of acute leukemia and blast crisis of chronic myeloid leukemia].
    Savchenko VG; Isaev VG; Abakumov EM; Khoroshko ND; Turkina AG; Sokolov AN; Viadro MM; Navashin SM
    Antibiot Khimioter; 1992 Jul; 37(7):47-9. PubMed ID: 1456812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.